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HIGH RISK ALCOHOL USE AFTER SLEEVE GASTRECTOMY 
EMILY KATHERINE WONG 
ABSTRACT 
 Obesity is a major health problem associated with a plethora of health risks and a 
high economic cost in the United States. While non-surgical treatment options exist, 
surgical treatments have been shown to provide better success with weight-loss long 
term. Despite its success, an early type of weight loss surgery (WLS) called Roux-en-Y 
Gastric Bypass (RYGB) has been linked to a higher risk of alcohol consumption post-
operatively; however, the potential risk between the newer, more commonly performed 
surgery, sleeve gastrectomy, has yet to be explored. This pilot study conducted at the 
Bariatric Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts, will 
provide preliminary data on high-risk alcohol use before and after sleeve gastrectomy 
(SG). Patients were interviewed regarding eating and drinking behaviors before and after 
SG using modified versions of the Three Factor Eating Questionnaire Revised-18 and the 
Alcohol Use Disorder Identification Test-C respectively. In this interim analysis, 37 of 70 
eligible subjects underwent the baseline questionnaire (52.9% participation) and out of 
the 9 participants who had 3-month follow-ups, 8 participants completed their interview 
(88.9% retention). The overall prevalence of high-risk drinkers at baseline was 27%. 
Among the 8 participants who completed the 3-month follow-up, 1 reported high-risk 
drinking baseline and none reported high risk alcohol use at follow-up. In conclusion, 
although 27% of patients were high-risk drinkers at baseline, none of the patients were 
high-risk drinkers at the 3-month follow-up. Future studies investigating the change of 
		 v 
alcohol use after longer-time periods after weight loss surgery are necessary in order to 
better assess if there is an increased alcohol use after sleeve gastrectomy. 
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INTRODUCTION 
 
1. The Health Problem of Obesity 
a) Prevalence and Body Mass Index 
According to the Center of Disease Control (CDC), more than one-third of adults 
and almost one-fifth of youth in the United States are obese. Obesity is characterized as 
weight that is above what is considered healthy for a given height. Body mass index 
(BMI) is often used by healthcare professionals as a screening tool for overweight or 
obese patients. BMI does not measure fat directly, but is a proxy for body fat and is 
defined by weight in pounds divided by height in meters squared. Classifications for 
various BMI’s are categorized in Table 1. Overall, BMI is an inexpensive and simple way 
for clinicians to screen for a patient’s weight category. 
Table 1. Classification for various ranges of body mass index  
 
Body Mass Index (Kg/M2) Classification 
Less than 18.5 Underweight 
18.5 to 24.9 Normal 
25.0 to 29.9 Overweight 
30 to 34.9 Class 1 Obese 
35 to 39.9 Class 2 Obese 
40 or greater Class 3 Obese 
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b) Obesity Causes 
Obesity is a multifaceted health issue that may be caused by a combination of 
genetic, behavioral, and environmental factors. Genetics factors are estimated to 
contribute 40% to 70% of a person’s susceptibility to obesity (Herrera & Lindgren, 2010) 
and include factors such as resting metabolic rate (RMR), prenatal determinants, specific 
gene loci, and altered gut microbiome. Studies have shown that resting metabolic rate per 
total body mass is lower for both sexes of obese adults compared to non-obese adults and 
that this low RMR is likely to contribute to greater weight gain (Astrup et al., 1999; 
McMurray, Soares, Caspersen, & McCurdy, 2014). Other studies recognize that prenatal 
environmental and nutritional exposures may influence the structure and function of 
organs and may play a role in obesity later on as adults. For example, mothers who 
gained excessive weight while pregnant had children with a greater risk of being 
overweight during childhood. (Oken, Taveras, Kleinman, Rich-Edwards, & Gillman, 
2007). Further examination of the genetic role in obesity has led to the identification of 
over 58 loci linked to obesity (Choquet & Meyre, 2011). Many of these genes are 
suggested to play a role in the regulation of food intake through hunger, satiety, and 
overall adipocyte function (Herrera & Lindgren, 2010). Studies investigating the link 
between gut microbiota and obesity have shown that an altered gut microbiome may 
promote insulin resistance, induce short chain fatty acid production, create changes in 
lipoprotein and bile acid metabolism, stimulate hormones, and cause systemic 
inflammation  (Jiao et al., 2018; Khan, Gerasimidis, Edwards, & Shaikh, 2016). 
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Additionally, deviations in energy requirements such as taste preferences, fuel utilization, 
and muscle metabolic characteristics may play a genetic role in obesity as well (Weinsier, 
Hunter, Heini, Goran, & Sell, 1998). More rare genetic contributions include leptin 
deficiency and defects in other hunger-related receptors, Prader-Willi syndrome, 
hypothalamic injury, and endocrine disorders that are linked to increased body fat and 
obesity (Weinsier et al., 1998). Although genetics may play a role if one is more 
predisposed to being obese, other factors such as eating and drinking habits, physical 
activity levels, medication use, education, exposure to food marketing and promotion, 
and even socioeconomic factors contribute greatly to the prevalence of obesity (Kelishadi 
& Azizi-Soleiman, 2014).  Societal, demographic and cultural differences in physical 
activity levels and food consumption patterns play a role in the imbalance between 
energy intake and expenditure (Serra-Majem & Bautista-Castaño, 2013). Poor diet and 
unhealthy eating choices involve eating processed foods, high carbohydrate or high fat 
foods, drinking excessive amounts of alcohol, having large portion sizes, or comfort 
eating (Australia, 2016). There is also a significant link between the consumption of low 
quality, high caloric foods due to economic factors which contributes to obesity in lower 
socioeconomic status populations (Akil & Ahmad, 2011). Overall, obesity is a 
manifestation of a number of genetic, environmental, and behavioral factors that vary 
from person to person. 
c) Obesity Health Risks 
Obesity is associated with a plethora of health risks including: amplified risk of 
mortality, diabetes mellitus, hypertension, hypercholesterolemia, asthma, arthritis, stroke, 
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cardiovascular diseases and certain cancers (Bhaskaran et al., 2014; Hammond & Levine, 
2010). Overall, obesity leads to impaired physical function and mobility disability is 
associated with reduced quality of life (Forhan & Gill, 2013). In addition, a study 
examining mental health and obesity found preliminary data indicating that higher BMI 
was associated with poorer mental health (Vella Baldacchino, Sacco, Caruana, Vella 
Baldacchino, & Deguara, 2015) while another study identified a high incidence of 
psychological co-morbidities, including symptoms of anxiety and depression, and overall 
reduced quality of life for obese individuals.  (Jagielski, Brown, Hosseini-Araghi, 
Thomas, & Taheri, 2014). Obesity is a serious concern due to its association with these 
physiological and psychological comorbidities, and is one the leading causes of 
preventable death in the U.S. (Kushner, 2002).  
d) Economic costs 
Medical costs associated with obesity and its related health problems have 
contributed to a substantial economic burden on the U.S. healthcare system. Direct 
medical expenses related to obesity involve preventative, diagnostic, and treatment 
services, indirect medical expenses may include morbidity and mortality costs (Office of 
the Surgeon General (US), Office of Disease Prevention and Health Promotion (US), 
Centers for Disease Control and Prevention (US), & National Institutes of Health (US), 
2001).  In 2008, the United States direct medical care costs for obesity was estimated to 
be 147 billion dollars (Finkelstein, Trogdon, Cohen, & Dietz, 2009), and in 2014, the 
global economic impact was estimated to be two trillion dollars, or approximately 2.8% 
of the global gross domestic product (Tremmel, Gerdtham, Nilsson, & Saha, 2017). This 
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estimate does not include indirect costs such a loss of work productivity including costs 
due to employees being absent from work due to obesity-related health issues, decreased 
productivity of employees, as well as premature mortality and disability (Dee et al., 
2014). The overall economic impact of obesity accentuates the importance of future 
research into this topic and the corresponding ways to prevent and treat obesity and its 
comorbidities. 
2. Nonsurgical Weight Loss Treatments  
a) Behavioral Interventions 
Behavioral treatment is often the first method of intervention for overweight and 
obese patients. Strategies for weight loss often include high amounts of physical activity 
and dietary strategies. Weight loss programs focus on constructing long-term skills for 
weight loss and management and often use group-treatment as it is cost-effective and 
provides a combination of social support, competition, and empathy. A comprehensive 
behavioral approach will include goal setting, self-monitoring, stimulus control, and 
frequent contact and follow-up with a health provider (Butryn, Webb, & Wadden, 2011). 
Patients treated with intensive behavioral interventions can lose approximately 8 to 10 kg 
or 8-10% of initial weight and approximately 80% of patients who begin this intervention 
will complete it (Wadden, Butryn, & Wilson, 2007). However, weight regain often 
begins once this treatment is over, with about one-third of lost weight being regained 
within one year of treatment ending and nearly half of patients returning to their original 
weight within five years (Butryn et al., 2011). Because these weight loss patients are 
challenged by environmental influences and require long-term vigilance in regards to 
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eating behaviors and physical activities, behavioral interventions are not always the most 
effective method of weight loss for some patients.  
b) Pharmacotherapy  
Over the last several years, the FDA has approved short and long-term 
medications for the treatment of obesity; these are often used in conjunction with 
behavioral treatment. Several studies indicated that the addition of weight loss 
medications to comprehensive behavioral treatment significantly improved weight loss 
over each treatment separately (Phelan & Wadden, 2002; Wadden et al., 2005). FDA-
approved weight loss drugs include Belviq, Contrave, Meridia, Qsymia, Redux, Saxenda 
(“FDA Approved Drugs by Medical Condition | CenterWatch,” n.d.). The idea behind 
combining these two treatments is that behavioral treatment deals with the external 
environment involving food and dietary choices, while pharmacological prescriptions 
involve the internal environment by reducing hunger, cravings or by altering nutrient 
absorption (Phelan & Wadden, 2002).  However, lack of reimbursement for these 
medications, unrealistic treatment expectations leading to high attrition, issues on safety 
and efficacy, potential misuse of medications due to weight stigma, and risks of 
withdrawal indicate that pharmacological interventions may not be the best choice of 
treatment for obese patients (Yanovski & Yanovski, 2014). 
3. Weight Loss Surgery Treatment Models 
a) Rou-en-Y Gastric Bypass, Sleeve Gastrectomy, Adjustable Gastric Band 
Unlike lifestyle and pharmacological prescriptions, weight loss surgery has been 
shown to produce substantial and sustained weight loss. Consequently, there has been a 
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rise in weight loss surgeries (WLS) over the last two decades, including Rou-en-Y gastric 
bypass (RYGB), sleeve gastrectomy (SG), and adjustable gastric band (AGB) procedures 
(Angrisani et al., 2015). Figure 1 compares the physiological differences between these 
three surgeries below. The Roux-en-Y gastric bypass procedure involves surgically 
taking a small area of the stomach and directly attaching it to a later part of the small 
intestine which thus bypasses a majority of the stomach and part of the small intestine 
called the duodenum. In the gastric sleeve procedure, a surgeon resects a large portion of 
the stomach, leaving a smaller stomach known as the ‘gastric sleeve’ for which the 
smaller size limits the amount of food that can be eaten. The adjustable gastric banding 
procedure involves inserting a band around the upper part of the stomach to produce a 
small pouch for food, restricting the amount of food that can be eaten without physically 
removing any part of the stomach. 
Figure 1: Weight loss surgery types (Nielsen, Svane, Bojsen-Møller, & Madsbad, n.d.) 
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These procedures typically result in greater weight loss than nonsurgical 
therapies, a decrease in weight-related health problems and improved quality of life 
(Coulman, MacKichan, Blazeby, & Owen-Smith, 2017). RYGB is the oldest of these 
procedures and produces the greatest weight loss, followed closely by sleeve gastrectomy 
and with gastric banding being the least effective (Nielsen et al., n.d.). Thus, weight loss 
surgery has appeared as the most effective treatment for patients with severe obesity with 
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over 200,000 patients undergoing these procedures in the United States in 2016 (O’Brien, 
McPhail, Chaston, & Dixon, 2006; Sjöström et al., 2004).  
b) Complications of Surgeries 
Acute complications of weight loss surgery, which occur in about 5 to 10% of 
patients, include hemorrhage, anastomotic leaks, abdominal pain, infection, obstruction, 
pulmonary emboli, arrhythmias (Pories, 2008). While the acute complications of weight 
loss surgery are similar for all three surgery types, long-term complications vary greatly. 
As Roux-En-Y gastric bypass has been shown to cause malabsorption, a patient with 
vitamin and mineral deficiencies may be advised by their physician against this procedure 
as it may exacerbate these issues (Sawaya, Jaffe, Friedenberg, & Friedenberg, 2012). 
Although nutritional deficiencies in obese patients may seem paradoxical, consumption 
of excessive calories does not equate to ingestion of high-quality, nutrient dense foods. 
Thus, many obese people have iron deficiencies in and/ or insufficient levels of vitamins 
D, B12, E, and C that must be screened and accounted for before a patient undergoes 
weight loss surgery (Xanthakos, 2009). To address these deficiencies, patients are often 
put on the necessary nutritional supplements pre-and post-operatively. 
The sleeve gastrectomy procedure is associated with an increased rate of 
gastroesophageal reflux reported post-operatively that is caused either as a direct result of 
the surgery itself or as an aggravation of preexisting symptoms (Stenard & Iannelli, 
2015). This complication of reflux, in addition to having potential nutritional deficiencies 
for the gastric sleeve may lead physicians to advise patients with severe gastroesophageal 
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reflux to choose a different type or surgery or to take preventative measures such as 
taking a proton pump inhibitor post-operatively.  
Despite being minimally invasive, complications regarding the gastric band 
include band erosion, pouch slippage, catheter- or port-related problems (Suter, Calmes, 
Paroz, & Giusti, 2006), in addition to esophageal and pulmonary complications (Jalota, 
Oluwasanjo, & Alweis, 2014).This procedure may not be advisable for patients with 
asthma or gastroesophageal reflux as a result of these complications. Examining both 
lifestyle habits and medical comorbidities are thus critically important to medical 
decision making, especially regarding the choice between the various procedures for 
weight loss surgery.  
c) Increased Alcohol Use after WLS 
In addition to the known complications, emerging evidence has shown that WLS 
patients have an increased risk for developing risky alcohol use and/or alcohol use 
disorder (AUD) which may contribute to an increase of risky behaviors and other health 
complications observed after bariatric surgery (Suzuki, Haimovici, & Chang, 2012). As 
heavy alcohol use can often lead to serious medical consequences, factors that are 
responsible for increasing the risk of AUD should be greatly scrutinized before 
considering WLS. Most of the research on the increased risk of alcohol misuse after WLS 
are based on the older bariatric procedure called Roux-en-Y gastric bypass (RYGB). 
Although still performed, RYGB is no longer the leading WLS procedure as its 
prevalence has decreased from an estimated 36.7% in 2011 to 18.7% in 2016 according 
to the American Society for Metabolic and Bariatric Surgery (ASMBS). As this 
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procedure has decreased, the now more commonly performed WLS procedure in the 
United States, the sleeve gastrectomy, has been increasing in prevalence from 17.8% in 
2011 to 58.1% in 2016 (ASMBS). Meanwhile a third type of surgery, the adjustable 
gastric band, has decreased in prevalence from 35.4% in 2011 to 3.4% in 2016 (Angrisani 
et al., 2015).  
The Roux-en-Y gastric bypass procedure creates a small stomach pouch which 
holds less food and skips the beginning section of the small intestine, in which most 
absorption occurs, thus fat absorption is reduced and the pharmacokinetics of the stomach 
are altered (Brocks, Ben-Eltriki, Gabr, & Padwal, 2012). Previous studies have shown 
that RYGB causes a reduction in alcohol passage time from stomach to the small 
intestine, where eighty percent of alcohol is absorbed, thus RYGB patients will have 
increased rate of transport of alcohol into the bloodstream, giving a greater feeling of 
drunkenness (Pepino et al., 2015). This altered absorption of alcohol across the 
gastrointestinal tract leads to a heightened sensitivity to alcohol and is theorized to 
facilitate alcohol dependence. One study examined peak breath alcohol content of 
patients who underwent RYGB after ingesting a specified alcohol dose and found that it 
took longer to return to sobriety later in the postoperative period compared to pre-
operatively (Woodard, Downey, Hernandez-Boussard, & Morton, 2011). Another small 
study reported more rapid alcohol absorption in women after RYGB surgery compared to 
match controls (Klockhoff, Näslund, & Jones, 2002). This theory in combination with 
various studies examining increased risk of alcohol use and its related symptoms have 
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prompted many to postulate that alcohol misuse arises after RYGB due to the surgical 
change in physiology creating altered alcohol absorption (Brocks et al., 2012). 
However, other studies reported a rise in alcohol misuse after adjustable gastric 
banding (ABG), contradicting the theory that alcohol misuse is due to physiological 
changes creating altered absorption of alcohol (Wee et al., 2014). The gastric band does 
not involve physically removing or changing any part of the stomach or small intestine 
and thus should not change the pharmacokinetics like RYGB is shown to do. Similarly, 
other contradicting studies have shown that AGB is not linked to having increased 
alcohol use, leading to the proposal of several mechanisms to explain the observable 
differences in alcohol use after bariatric surgery (Mehr, 2014; Suzuki et al., 2012).  
Evidence that other gastro-restrictive procedures lead to increase alcohol misuse 
after WLS has led to additional hypotheses to potentially explain this phenomenon. One 
such theory involves psychological factors in addition to purely physiological ones. 
Emerging data suggests that WLS may affect the neural processing of how patients 
evaluate food and food cues (Scholtz et al., 2014; Scholtz, Goldstone, & le Roux, 2015).  
One related hypothesis is the “addiction transfer” model in which one trades their 
food addiction for a substance such as alcohol or other drugs as a coping mechanism. A 
small study focusing on feeding peptides secreted by the gastrointestinal tract provided 
evidence that there may be other mechanisms by which WLS-induced alcohol intake 
changes occur separate from the previous gut absorption of alcohol theory. Ghrelin, an 
important hormone produced in the stomach for the regulation of appetite, had changes in 
its levels after WLS, leading to its possible role in addiction transfer (Brodie, Pesold, & 
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Appel, 1999). Ghrelin levels rise during periods of fasting or dieting, stimulates hunger 
and increases motivation to obtain food. Evidence of reduced basal ghrelin levels during 
early periods of gut remodeling after RYGB led to the implication that reduced ghrelin 
levels led to decreased appetite and thus less food intake that helped aid in weight loss 
post-surgery (Davis, Choi, Clegg, & Benoit, 2011).  Other studies however, provided 
evidence that RYGB ultimately induces gastrointestinal secretory cells to produce and 
release elevated ghrelin levels at 6-12 months following WLS, which corresponds to 
periods of increased alcohol intake in RYGB patients (le Roux et al., 2007; Shin, Zheng, 
Pistell, & Berthoud, 2011). A study providing data on alcoholic patients, who were given 
measured quantities of exogenous ghrelin, showed induced alcohol cravings and thus 
provided evidence for changes in ghrelin levels leading to increased alcohol use after 
WLS (Ostlund et al., 2013). 
To negate the possibility of an addiction transfer, clinicians may use standardized 
assessments to evaluate if a patient is addicted to food, offer psychological counseling 
and make sure the person has a good social support group (Meule, Heckel, Jurowich, 
Vögele, & Kübler, 2014). Another hypothesis is that there was already a small population 
of patients with high-risk alcoholic tendencies getting WLS and that their lifestyle 
changes post-operatively spurred them to increase their use further. If this is the case, it is 
recommended to ask for one year of sobriety before undergoing surgery (Mehr, 2014). 
Since there is no exact cause of increased alcohol use after bariatric surgery, it is 
necessary for further research to be done in order to identify patients who may have an 
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escalated chance for high-risk alcohol use and to assess the best plan of treatment for 
them. 
d) Rationale for Investigating Alcohol Use After Sleeve Gastrectomy  
The gastric sleeve shares mechanistic similarities to RYGB, making it another 
surgery with a potentially comparable risk of alcohol misuse. Although the creation of the 
gastric sleeve avoids creating a gastrointestinal bypass, which is the hypothesized reason 
for greater alcohol absorption seen in RYGB, the literature is highly controversial about 
the gastric sleeve’s link to increased alcohol use. While two small studies, with 16 and 10 
study subjects respectively, showed no increase in alcohol absorption after sleeve 
gastrectomy, a third study exhibited significantly higher peak alcohol levels a few months 
following the sleeve procedure (Changchien, Woodard, Hernandez-Boussard, & Morton, 
2012; Gallo et al., 2015; Maluenda et al., 2010). Evidence that the gastric sleeve alters 
release of ghrelin levels indicates its possibility in increasing alcohol use similar to 
RYGB; however, significant data is lacking and have included only small sample sizes 
with less than 17 subjects, limiting the amount of reliability and generalizability of the 
data. To date, there is a lack of data examining whether the sleeve gastrectomy 
procedure, as the newer and increasingly prevalent surgery, poses a risk of alcohol 
misuse. Given the data that alcohol misuse is observed after two other weight surgeries, 
RYGB and gastric banding, it stands to reason that it is worth investigating the likelihood 
of increased alcohol misuse after sleeve gastrectomy as well. Especially since the gastric 
sleeve procedure is now the leading WLS performed in the US and that there is potential 
link between alcohol misuse and its associated risks, it would be of great benefit to 
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examine the link between this surgery and high-risk drinking in order to have informed 
medical decision-making and risk stratification for patients.  
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SPECIFIC AIMS 	
The first aim of our study is to characterize the potential risk of high risk alcohol 
use for patients undergoing sleeve gastrectomy and to have this serve as preliminary data 
for a larger study. 
The second aim is to explore potential patient characteristics that may contribute 
to their risk of alcohol misuse.
	17 
 
METHODS 
 
1. Overview and Study Sample 
Study subjects were systematically recruited from the Bariatric Surgery Center at 
Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. National 
Institutes of Health (NIH) criteria was used to determine eligibility for surgery namely 
either a BMI of 40 Kg/M2 or a BMI of 35 Kg/M2 with a major obesity-related 
comorbidity. Eligible patients were age 18 or older, English-speaking, willing and able to 
take part in telephone interviews, planning to undergo sleeve gastrectomy, enrolled prior 
to their surgery and whose physicians permitted us to contact them. After permission 
from their physician was granted, eligible patients were sent letters and called after a two-
week waiting period. The study was approved by the institutional review boards at Beth 
Israel Deaconess Medical Center.   
2. Data Collection and Assessment 
With approval from a HIPAA waiver, research staff reviewed the BIDMC 
bariatric appointment center’s schedule in order to identify eligible patients scheduled to 
get the sleeve gastrectomy procedure. Patient’s medical history were reviewed and kept 
in a secure data set in REDCap – a secure, web-based program devised to capture data for 
research studies. Records of important dates were kept in REDcap to mark: when patients 
were cleared by the bariatric center for surgery, when the bariatric physicians were 
emailed for permission to contact patients, when an eligible patient was contacted by 
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mail, and when a patient was contacted by phone. For data capture, REDCap’s survey 
forms were created and completed during the interview so that data was entered as it was 
being collected. Each study participant was given a unique study ID in order to protect 
patient confidentiality, and data used in analyses were de-identified. A master data sheet 
that links participant name with their study ID was kept on a secure sheet only accessible 
to research stuff. All electronic data was stored on password-protected computers on a 
secure server behind Beth Israel Deaconess Medical Center’s firewall.  
Research participants underwent approximately a ten-minute telephone interview 
at baseline, then a five-minute interview at their three-month follow-up after WLS. 
Continuation of the project will recruit more patients and conduct interviews at 6 and 12 
month periods for previously enrolled patients. These phone interviews collected 
demographic information such as race/ethnicity, marital status, and education and eating 
and alcohol intake behaviors. In addition, detailed medical comorbidities were assessed 
from medical record extraction to supplement information on possible risk-factors for 
participants.  
3. Measures of Alcohol Use and Cravings 
In order to assess alcohol related behaviors, we used the Alcohol Use Disorder 
Identification Test (AUDIT) questionnaire which has been validated in six different 
countries. The World Health Organization developed this questionnaire in order to 
recognize patients at risk for alcohol abuse. In order to assess alcohol use and high-risk 
drinking, we used the Alcohol Use Disorder Identification Test-C or AUDIT-C which is a 
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modified version of the validated 10-item questionnaire that performs better in 
identifying heavy drinkers and/or those with active alcohol dependence. The AUDIT-C is 
a 3-item questionnaire that is used to identify people who are high-risk drinkers or who 
have active alcohol use disorders. The AUDIT-C is used to assess frequency of drinking 
over the past year, the average amount of alcohol consumed during drinking sessions, and 
binge drinking over the past year. Our study added a modified version of the third item to 
reflect binge drinking over the past month, which is defined as five or more drinks on one 
occasion, in order to improve accuracy in reporting in the context of a telephone 
interview and to be more consistent with the definition of binge drinking set by the 
National Institutes of Alcohol Abuse and Alcoholism. Patients who responded to drinking 
more than 1 or 2 drinks on an average day or who had at least one instance of binge 
drinking in the last month were then asked a modified version of the remaining seven 
AUDIT items related to alcohol dependency and harmful alcohol use. Topics related to 
alcohol dependency included: issues over impaired control over drinking, noticeable 
increase of drinking, and morning drinking. Topics related to harmful alcohol included: 
feeling guilty after drinking, blacking out, having alcohol-related injury, and concerns 
about drinking by others. Scores for the AUDIT-C range between 0-12: where high risk 
drinking (our primary outcome) was defined as a score greater than or equal to four in 
men and greater than or equal to three for women. These scores have a high sensitivity 
and specificity in identifying heavy drinking and/or active alcohol abuse or dependence. 
Subjects who scored 8 or higher out of 40 on the full AUDIT questionnaire were 
classified as having alcohol abuse or dependency disorders, which was our secondary 
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outcome. We chose to define our outcomes this way in order to maximize our power to 
detect differences across comparison groups. We also adapted several items from the 
National Alcohol Survey to ask about the largest quantity of lifetime alcohol use for 
current and ex-drinkers. This was done in order to identify heavy former-drinkers in our 
sample. In order to increase the reliability of responses, patients were informed that their 
responses would remain confidential and would not be part of their medical record. 
4. Measures of Food Cravings and Eating Behaviors 
In order to assess for the possibility of food addiction transfer, we used measured 
food craving and eating behavior using the Three Factor Eating Questionnaire Revised-
18 (TFEQ-R18). The TFEQ-R18 is an 18-item questionnaire that identifies cognitive 
restraint, uncontrolled eating, and emotional eating in which higher scores indicated a 
greater display of the respective disordered eating behavior. Raw scores were taken over 
the highest possible score and multiplied by 100 in order to get a percentage in each 
disordered eating category. Those with a score of 50% or higher indicated a high amount 
of disorder for their respective eating category. 
5. Data Analysis 
We used descriptive statistics, conducted with SAS (SAS Institute, Cary, USA), 
to characterize our sample and examine the proportion of high risk alcohol drinkers at 
baseline compared to at follow-ups in this interim analysis. However, due to time 
constraints, formal statistical comparisons were not conducted but will be done in the 
future. Once we have achieved our target sample of 150, we will make our hypothesis 
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and determine whether sleeve gastrectomy is associated with by using Pearson chi-square 
tests in order to compare the proportion of high-risk drinkers at baseline compared to 
each follow-up time frame post-surgery. We estimate that the 1 year response rate to our 
follow-up interview will be between 80-90%, leaving us with approximately 120-135 
participants with complete baseline and follow-up alcohol use and food addiction data. 
We will examine baseline demographics between those who developed high risk drinking 
versus those who did not. T-tests will be used for continuous exposure variables and chi-
square tests for categorical exposures. We will also examine whether patients who 
exhibited disordered eating behavior at baseline including being prone to emotional 
eating or having addiction towards food are more likely to report high risk drinking in 
follow-up.  
6. Dissemination of Research Results in the Future 
At the end of their follow-up interview, research participants will be asked if they 
are interested in receiving the final results from this study. Research staff will explain 
that it may take several years before results are available. A record will be kept of the 
participants who are interested in learning the results and a summary of the findings will 
be sent to patients when available. In the letter, research staff will reference any 
publications resulting from the study. 
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RESULTS 
 
 
Of the 70 people contacted by phone, 37 completed the baseline interview and 8 
had their 3-month follow-up. One study subject completed the eating behavior 
questionnaire but did not complete the rest of the survey including the items on alcohol 
use.  The overall study participant rate was 52.6% and 88.9% of participants were 
retained at the three-month mark. The baseline characteristics of our overall study 
participants and those who completed the 3-month follow-up are presented in Table 2. 
Out of our 38 study participants, 73.6% were female and 26.3% were male, the mean age 
was 43 years old, and the mean BMI was 43.1 kg/m2 at baseline. The race of study 
participants was approximately 62.2% Caucasian, 24.3% African American, 2.7% 
Hispanic, and 10.8% other. Those who completed the 3-month follow-up were 62.5% 
female and 37.5% male; their mean age was 43, and their mean BMI was 44.2	kg/m2.  
Table 2: Baseline characteristics of study subjects 
  
All 
(n = 37) 
 
Participants with 3 month FU, 
(n=8) 
Age, mean (sd) 43.2 (11.2) 43.6 (13.9) 
Sex 
     Male 
     Female 
 
26.3% 
73.6% 
 
37.5%  
62.5% 
Race 
     Caucasian 
     African American 
     Hispanic 
     Other 
 
 
62.6% 
24.3% 
2.7% 
10.8% 
 
62.5% 
12.5%  
25% 
0% 
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Table 3 presents the alcohol use and eating behavior of our sample overall and the 
subset who completed in the 3-month follow-up thus far. The overall prevalence of high-
risk drinkers at baseline was 27%. Among the participants who completed the 3-month 
follow-up, the prevalence of high-risk drinking was 12.5% at baseline and 0% at follow-
up. Table 2 also displays the percentage of disordered eating for cognitive restraint, 
uncontrolled eating, and emotional eating at baseline compared to 3 months after WLS. 
Table 3: High risk drinking and eating behavior among subjects before (n=37) and 
after Sleeve Gastrectomy (n=8) 
  
Baseline 
all subjects (n=37) 
Baseline, 
subgroup with 3-month 
follow-up (n=8)  
 
3-Month FU, 
subgroup (n=8) 
# High-Risk Drinkers 10 1 0 
AUDIT Score 1.91 (1.89) 1.25 (1.38) 0.25 (0.70) 
Cognitive Restraint 57.15 (17.39) 63.5 (19.87) 42.5 (13.16) 
Uncontrolled Eating 35.38 (21.22) 32.87 (17.64) 7.40 (6.26) 
Emotional Eating 31.28 (20.80) 26.38 (17.75) 12.5 (15.06) 
  
BMI, mean (sd) 44.9 (5.2) 44.2 (2.7) 
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DISCUSSION 	
Regarding the baseline characteristics of our study participants, we found that a 
majority of our participants were female, middle aged, and had a BMI that is classified as 
class 3 obese. A majority of our participants identified their race to be Caucasian. In 
comparison, the baseline characteristics of those who did the 3-month follow-up were 
also Caucasian, about the same age, had a slightly lower percentage of females, and had a 
BMI classified as class 3 obese. Continuation of the study will be used to identify major 
differences between the characteristics of patients before and after weight loss surgery, 
including medical comorbidities. 
Our study found that 10 out of the 37 participants in our study reported high risk 
drinking at baseline with 1 out of 8 study participants having a follow-up. None of the 8 
study participants were high-risk drinkers at the 3 month-follow up. The lack of study 
participants who reported high-risk drinking at the three-month follow-up is 
understandable due to the recommendations by their surgeons and their bariatric center 
physician to refrain from drinking until at least six months after their surgery date. The 
one participant who was a high-risk drinker at baseline, was also the only who still 
reported consuming alcohol, however, not to the level of being high-risk. This 
consumption of alcohol, however, may still pose a risk to complicating post-operative 
recovery. Overall, there was a decrease in the mean AUDIT-C score from 1.91 at 
baseline to 0.25 at the 3-month follow-up reflecting that on average, our study 
participants greatly reduced their drinking behaviors.  
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Our study is consistent with past studies that showed there was no alteration of 
alcohol metabolism, and thus there would not be an increase of alcohol use after sleeve 
gastrectomy (Changchien, Woodard, Hernandez-Boussard, & Morton, 2012; Gallo et al., 
2015) due to the hypothesis that changes of alcohol metabolism in the body led to 
changes in drinking behaviors. A similar study examining the frequency and amount of 
alcohol use after sleeve gastrectomy using the AUDIT found that alcohol preference 
decreased at the 1 year follow-up (Coluzzi, Iossa, Spinetti, & Silecchia, 2018) which is 
similar to our findings, however, our 3 month follow-up time frame is too short to 
accurately compare to this, and other studies looking at changes in alcohol consumption 
at one or two year follow-up time frames. 
Our finding that 27% of our participants were high-risk drinkers was similar to 
the study by Wee et al., 2014 that found 19% of patients undergoing RYGB and 
adjustable gastric banding were high-risk drinkers, however our baseline prevalence of 
high risk drinking was higher than the prevalence found in that study. Since our studies 
were similar in the way we assessed and defined high-risk drinking and that our study 
population came from a WLS center in Boston, Massachusetts, it is possible that this 
difference may be a due to our small sample size overestimating the number of people 
with high-risk or that the population receiving sleeve gastrectomy differs from that of 
RYGB or AGB. The latter hypothesis is why it is critically important to continue this 
study to investigate whether there is truly a significant difference between changes in 
alcohol use for those undergoing sleeve gastrectomy. 
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Although our follow-up time at 3 months is constrained, it is interesting to see 
that the study participants improved in their pattern of alcohol use rather than worsening 
their behaviors. However, whether this finding will change with a bigger sample size or 
at the 6 and 12-month follow-ups remains to be determined. Although only one person 
was high-risk at baseline, it is important to note that this study participant’s behaviors 
seemed to not change much even post-operatively. WLS might affect patients in different 
and complex ways, making it important to recognize the different aspects that might be 
associated with increased or decreased drinking after surgery. Factors that may affect 
study participants post-operatively include their warning from their doctor, their decrease 
of food intake and diet, and any physiological or psychological side effects from the 
procedure. As these patients had to undergo dietary counseling through the bariatric 
center before receiving surgery, their eating and drinking behaviors may have been 
improved, however, they may also begin relapse or regress in these behaviors as more 
time passes from having received any counseling. Physiological changes may include 
having a now small stomach or changes in gut hormones such as ghrelin or GLP-1 as 
shown in a study investigating rats who underwent the equivalent of RYGB vs a control 
and found a reduction of alcohol intake after surgery (Saules et al., 2010) . This study 
found an increase in GLP-1, which has been shown to be a taste aversive element in rats 
and a decrease in ghrelin, the gut hormone for eating stimulation which appeared to 
control alcohol consumption levels. Whether these changes in hormones in rats may be 
applied to humans is unclear, but is consistent with our findings that there was an 
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apparent decrease in alcohol consumption post-operatively in a majority of our post-
operative study participants.  
Our study also found that cognitive restraint was the greatest issue of disordered 
eating in our population, with uncontrolled eating being the next highest and emotional 
eating being slightly less than uncontrolled eating. Overall, disordered eating behaviors 
appeared lower from baseline to follow-up. Comparing baseline scores to follow-ups, we 
found that mean cognitive restraint scores decreased from 77.15 to 42.5, uncontrolled 
eating reduced from 35.38 to 7.40, and emotional eating decreased from 31.28 to 12.5. 
These reduced means reflect that disordered eating behaviors were greatly reduced which 
may be due to a restriction of diet post-operatively, or due to the dietary counseling 
received before surgery or psychological changes on how subjects viewed food due to 
physiological changes after surgery. The interpretation of how these decreased eating 
disorders may affect drinking behavior varies. Although our study appears to show a 
decrease in both eating disordered behaviors and drinking behaviors, it is possible that a 
decrease in disordered eating behaviors may support the theory of addiction transfer if 
continuation of the study finds high-risk drinking behavior at follow-up. 
Our results should be understood in context of our study’s limitations. Study 
participants were recruited from only Beth Israel Deaconess Medical Center in Boston, 
Massachusetts, and thus may not be generalizable to other settings and populations 
outside this geographic area. Our study measures were self-reported via phone survey, 
and thus it is possible that there was a reporting bias and under-reporting of eating and 
drinking behaviors. We tried to minimize bias by assuring patients that their responses 
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would remain confidential and were for research purposes only. Moreover, about 40% of 
patients receiving sleeve gastrectomy did not participate in our study; thus, the baseline 
rates of high-risk drinking among nonparticipants might have been different from our 
study participants. Therefore, it is possible our estimates of high-risk drinking are under-
estimated. Another limitation to this study includes having a lack of a control group. 
Changes attributable to sleeve gastrectomy may be changes generic to those attempting 
weight loss or due to regression to the mean. However, these preliminary findings will 
suggest a potential effect size that allows us to design a more robust future study.  
The major drawback of this thesis project was the limited sample size, which was 
in part due to a combination time constraints and limited funds available for a pilot study. 
Setting up the projecting and getting project approval by the IRB resulted in delay in 
starting the project. This constraint, in addition to the already limited time granted to 
conduct this project during one school year, contributes to the fact that this project must 
be continued another year to achieve the target sample of 150 patients. Another factor 
limiting sample size was the number of people signing up and getting cleared for surgery. 
In addition to having to meet NIH criteria, those undergoing weight loss surgery have 
many steps before they can be cleared for surgery. Examples of some, but not all of the 
steps include receiving nutritional education, being physiologically assessed, receiving 
blood tests to test for potential nutritional deficiencies, getting a sleep test to test for 
obstructive sleep apnea, and sometimes losing weight. Once they go through the 
aforementioned steps, the availability of patient surgeries is often limited by the 
surgeon’s schedule. Especially as this is a single site study with only one bariatric center, 
	29 
patients were limited to the amount of time available in a single surgeon’s schedule due 
to another surgeon changing hospitals. Similar to this, many patients eligible for 
recruitment were hindered from signing up for surgery due to limitations in their 
insurance coverage. A small percentage of potential patients who were cleared for 
surgery chose to do a different type of surgery instead, thus making them ineligible for 
our study. A few other patients that were identified were later deemed ineligible due to 
their primary language being a language other than English. Another limitation that 
contributes to the small sample size is the lack of incentive for patients to do the study 
and thus the relatively low participation rate.  Regarding follow-ups, another problem 
includes retention rate as those who did baselines may not feel inclined to answer the 
questionnaires repeatedly. Another small issue was that patients often confused this study 
with a different study that was more difficult to participate as it involved many trips to 
the hospital; however, this was clarified to patients that this was a separate, easy-to-do 
phone interview. 
One drawback of the eating questionnaire was that a question involved assessing 
cognitive restraint by asking about a patient’s desire to eat meat; however, one patient 
identified themselves as vegetarian which disregarded the purpose of the question. Due to 
the length of the eating questionnaire, one study participant chose not to complete the 
survey. Overall, because of our small sample size, we were underpowered to identify 
correlates of high-risk drinking after sleeve gastrectomy. 
In summary, we found that 27% of study participants were high-risk drinkers at 
baseline and were likely to report ceasing alcohol use at the 3-month follow-up. There 
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was also a decrease in all disordered eating behaviors. Overall, these are potential 
positive effects of undergoing sleeve gastrectomy as opposed to other nonsurgical 
methods. Whether the amount of high-risk drinking will change at 6 and 12-month 
follow-up remains unclear. As there is a lack of data for increased use after sleeve 
gastrectomy, it is important to continue exploring these potential risks and clinicians 
should continue to caution against drinking after weight loss surgery since past studies 
have shown increased alcohol use. Future studies should examine why sleeve 
gastrectomy may either increase or decrease alcohol use and future studies should 
identify ways to minimize the risk of increase use.   
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